½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting


»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > Éú»¯ÊÔ¼Á > ¿¹ÌåËØÀà > àÑßÊÃ¹ËØÑÎËáÑÎ

²úÆ·ÖÐÐÄ

×îвúÆ·

  • àÑßÊÃ¹ËØÑÎËáÑÎ

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW28056
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100mg/25mg
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ £º àÑßÊÃ¹ËØÑÎËáÑΠ


ÆäËûÖÐÎÄÃû³Æ £º ¶þÇâÂÈ»¯àÑßʶ¾ËØ 


Ó¢ÎÄÃû³Æ £º Puromycin dihydrochloride 


ÆäËûÓ¢ÎÄÃû³Æ £º 3¡ä-[¦Á-Amino-p-methoxyhydrocinnamamido]-3¡ä-deoxy-N,N-dimethyladenosine dihydrochloride 


C A S £º 58-58-2 


C22H29N7O5?HC1=544.43


¼¶ ±ð £º Ultra Pure Grade


º¬ Á¿ £º ¡Ý98.0%


ÈÛ µã £º 165¡«172¡æ


Èܽâ¶ÈSolubility(5% water) £º Pass


²úÆ·ÃèÊö £º Protein synthesis inhibitor(causes premature chain termination by acting as an analog of aminoaxyl-tRNA) 


ÐÔ ×´ £º °×É«»òÀà°×É«·ÛÄ©


Óà ; £º Éú»¯Ñо¿¡£ÓɰÚÉèÁ´Çò¾ú·¢½ÍÖÆµÃµÄ¿¹ÉúËØ£¬Æä½á¹¹Óë°±»ùõ£tRNA·Ö×ÓÖÐÏÙÜÕÏàÁ¬µÄ°±»ùËáÄ©¶Ë½á¹¹ÏàËÆ£¬¿É×÷Ϊ°±»ùõ£tRNAµÄÀàËÆÎ´Ó¶øÈ¡´úһЩ°±»ùõ£tRNA½øÈëºËÌÇÌåAλÖã¬ÓëÕýÔÚÑÓÉìµÄ¶àëÄÁ´½áºÏ£¬µ±ÑÓ³¤ÖеÄëÄתÈë´ËÒì³£Aλʱ£¬ÈÝÒ×ÍÑÂ䣬ÒÔëÄ»ùàÑßÊÃ¹ËØµÄÐγɴӺËÌǵ°°×ÌåÉÏÔçÆÚ½âÀ룬ÖÕÖ¹ëÄÁ´ºÏ³É£¬Òò¶øµ¼Öµ°°×ÖʺϳɵÄÖÕÖ¹²¢ÊͷųöC-Ä©¶Ëº¬ÓÐàÑßÊÃ¹ËØµÄ²»³ÉÊì¶àëÄ¡£Ö÷ÒªÓÃ×öÑо¿µ°°×ÖʺϳɵÄÉúÎﻯѧ¹¤¾ß¡£ºËÜÕËΌÌ壬µ°°×ºÏ³ÉÒÖÖÆ¼Á¡£


±£ ´æ £º -20¡æ




¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿